重新分类非浸润性包裹性滤泡型甲状腺乳头状癌对外科影响的前瞻性评估
该研究回顾2006年至2016年病理报告,从1335例甲状腺乳头状癌中筛选出194例(14.5%)符合非浸润性滤泡性甲状腺肿瘤伴乳头状核特征(NIFTP)标准,排除合并其他恶性肿瘤及既往肺叶切除者后分析164例。52%行全甲状腺切除,48%行甲状腺肺叶切除,其中54%后续行全甲状腺切除,24%接受放射性碘治疗,随访>3个月者无复发。重新分类将减少无效治疗,但手术范围的实际影响仅涉及3.2%的甲状腺乳头状癌患者。
要点
- NIFTP重新分类预计可减少无效治疗并降低成本。
- 手术范围的实际影响仅限3.2%的甲状腺乳头状癌患者。
核心结论
- 将非浸润性包裹性滤泡型甲状腺乳头状癌重新分类为NIFTP将减少无效治疗并降低成本。
- 该变化对手术范围的影响仅限于3.2%的甲状腺乳头状癌患者,而非预计的18.6%。
研究设计与样本
- 回顾性分析2006年4月至2016年4月的病理报告,从1335例甲状腺乳头状癌中筛选出194例(14.5%)符合NIFTP标准。
- 排除合并其他甲状腺恶性肿瘤(n=25)及既往甲状腺肺叶切除(n=5)后,对剩余164例潜在NIFTP病例进行人口学、病理、治疗及随访数据分析。
- 采用逻辑回归分析评估细针穿刺结果与初始手术方式的关联。
主要发现
- 164例符合NIFTP标准的患者中,细针穿刺结果:无诊断意义2%、良性18%、异型性/意义未明的滤泡性病变26%、滤泡性肿瘤或可疑滤泡性肿瘤20%、可疑恶性19%、恶性6%、未获取9%。
- 79例(48%)以甲状腺肺叶切除为初始手术,其中54%(n=43,占所有甲状腺乳头状癌的3.2%)后续行全甲状腺切除,24%接受术后放射性碘治疗。
- 随访>3个月的125例患者中无复发。
临床怎么用
- 对于符合NIFTP标准的甲状腺结节,可考虑减少全甲状腺切除及术后放射性碘治疗,以降低无效治疗和成本。
- 细针穿刺结果为「可疑恶性」时,需注意其与全甲状腺切除的关联,结合NIFTP可能性权衡手术范围。
局限性
- 回顾性研究设计。
- 随访时间有限,仅125例随访>3个月。
- 排除了合并其他甲状腺恶性肿瘤及既往甲状腺肺叶切除的病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The reclassification of noninvasive encapsulated follicular variant of papillary thyroid cancer to noninvasive follicular thyroid neoplasm with papillary-like nuclear features will reduce nonefficacious and potentially harmful care. Reclassification is estimated in 18.6% of patients with papillary thyroid carcinoma; we aimed to quantify the implications of this change. METHODS: Pathology reports from April 2006 to April 2016 were reviewed to isolate cases that would have been designated as neoplasm with papillary-like nuclear features. Of the 1,335 cases of papillary thyroid carcinomas, 194 cases (14.5%) met criteria. Cases in which neoplasm with papillary-like nuclear features was found in combination with other thyroid malignancies (n = 25) and cases of prior thyroid lobectomy (n = 5) were excluded. Demographic, pathologic, treatment, and follow-up data were assessed for the remaining 164 potential neoplasm with papillary-like nuclear features cases. Logistic regression analysis was performed to evaluate association between fine-needle aspiration result and index procedure. RESULTS: Of the 164 patients with tumors who met neoplasm with papillary-like nuclear features criteria, fine-needle aspiration results were nondiagnostic (2%), benign (18%), atypia/follicular lesion of undetermined significance (26%), follicular neoplasm or suspicious for follicular neoplasm (20%), suspicious for malignancy (19%), malignant (6%), and not obtained (9%). Eighty-five (52%) patients underwent total thyroidectomy. A "suspicious for malignancy" fine-needle aspiration result was associated with undergoing total thyroidectomy versus thyroid lobectomy (P = .006). Thyroid lobectomy was the index procedure for 79 patients (48%); of these patients, 54% (n = 43, 3.2% of all patients with papillary thyroid carcinomas) underwent subsequent total thyroidectomy, and 24% received postoperative radioactive iodine treatment. There were no recurrences among the 125 patients with >3 months of follow-up. CONCLUSION: The reclassification of noninvasive encapsulated follicular variant of papillary thyroid cancer as neoplasm with papillary-like nuclear features will decrease nonefficacious treatment and reduce costs. However, the impact of this change with regard to extent of surgery was limited to 3.2% of patients with papillary thyroid carcinomas compared with the projected potential impact on 18.6%.
引用
- Mainthia R, Wachtel H, Chen Y, et al. Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Surgery. 2017. PMID: 29146229. doi:10.1016/j.surg.2017.04.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。